Simple Summary As of October 2021, over 245 million people have been infected and
nearly 5 million have died due to COVID-19. Atherosclerosis is a lipid-driven chronic …

Objective Among patients with Coronavirus disease 2019 (COVID-19), coronary artery
disease (CAD) has been identified as a high-risk condition. We aimed to assess the clinical …

Abstract Objective Since the World Health Organization (WHO) announced coronavirus
disease 2019 (COVID-19) had become a global pandemic on March 11, 2020, the number …

Observational studies have reported an association between underlying cardiovascular
diseases (CVD) and worse prognosis in COVID-19 patients, but this still remains unclear …

Objective Evaluate the risk of pre-existing comorbidities on COVID-19 mortality, and provide
clinical suggestions accordingly. Setting A nested case–control design using confirmed case …

Background A high prevalence of cardiovascular risk factors including age, male sex,
hypertension, diabetes, and tobacco use, has been reported in patients with Coronavirus …

Methods This is a retrospective study of patients who tested COVID-19 positive via reverse
transcriptase-PCR (RT-PCR) assay. We compared the characteristics and outcomes of …

Atherosclerosis is a chronic inflammatory and degenerative process that mainly occurs in
large-and medium-sized arteries and is morphologically characterized by asymmetric focal …

Aims This study aims to evaluate the short-and long-term associations between COVID-19
and development of cardiovascular disease (CVD) outcomes and mortality in the general …

Background A small minority of people with coronavirus disease 2019 (COVID‐19) develop
a severe illness, characterised by inflammation, microvascular damage and coagulopathy …